Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bedrocan Deutschland is the German subsidiary of Bedrocan International, the world's most experienced producer of legal medicinal cannabis. The company specializes in the production and distribution of standardized pharmaceutical-grade cannabis flos, ensuring consistent cannabinoid and terpene profiles for clinical use. Their products are used to treat a variety of conditions, including chronic pain, multiple sclerosis, and chemotherapy-induced nausea. Bedrocan is recognized for its rigorous quality control and adherence to Good Manufacturing Practice (GMP) standards, providing reliable options for patients and researchers. As the sole producer for the Dutch Office of Medicinal Cannabis, Bedrocan has set the global benchmark for medicinal cannabis quality. The German office facilitates access to these standardized therapies within the German healthcare system.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bedrocan Deutschland.